ArticleVaccines2020

Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer.

Sanjana Monirul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.